Chemistry:CS-27349

Short description: Chemical compound

CS-27349

Identifiers
IUPAC name (1R,2R,5S)-8-Methyl-8-azabicyclo[3.2.1]oct-2-yl hydroxy(diphenyl)acetate
CAS Number	64471-12-1 Y HCl: 64520-33-8
PubChem CID	3049185 HCl: 3049184
ChemSpider	143123 HCl: 57264798
ChEMBL	ChEMBL298138
CompTox Dashboard (EPA)	HCl: DTXSID90983151
Chemical and physical data
Formula	C22H25NO3
Molar mass	351.446 g·mol−1
3D model (JSmol)	Interactive image
SMILES CN1C2CC[C@H](C1CC2)OC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)O.Cl
InChI InChI=1S/C22H25NO3/c1-23-18-12-14-19(23)20(15-13-18)26-21(24)22(25,16-8-4-2-5-9-16)17-10-6-3-7-11-17/h2-11,18-20,25H,12-15H2,1H3/t18?,19?,20-/m1/s1 Key:LSJGAYNIIMEDLR-SOAGJPPSSA-N

CS-27349, or L-2-α-tropinyl benzilate, is an experimental incapacitating agent. It acts as an antagonist to muscarinic acetylcholine receptors, causing delirium. It has 37% of the potency of the related compound 3-quinuclidinyl benzilate (BZ) in producing peripheral effects, but 85% of the potency in producing central effects. The mean dose required to incapacitate subjects was 1.2 times that of BZ. It has not been in use since the 1970s, and there have been no publications about its effects or long-term toxicology since then.